| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |